Elite 50% OFF Act now – get top investing tools Register Now!

Gain Therapeutics, Inc.

Contributing Author

Recent Articles by Gain Therapeutics, Inc.

Nov-20	Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025 GANX GlobeNewswire
Nov-12	Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update GANX GlobeNewswire
Oct-30	Gain Therapeutics to Present at Neuroscience 2025 GANX GlobeNewswire
Oct-16	Gain Therapeutics to Attend the 2025 Maxim Growth Summit GANX GlobeNewswire
Oct-09	Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson's Disease GANX GlobeNewswire
Oct-06	Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson's Patients at International Congress of Parkinson's Disease and Movement Disorders GANX GlobeNewswire
Sep-23	Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025 GANX GlobeNewswire
Sep-18	Gain Therapeutics Begins Its GT-02287 Phase 1b Extension Study in People with Parkinson's Disease GANX GlobeNewswire
Sep-04	Gain Therapeutics Receives Australian Approval of Phase 1b Dosing Extension and Reports Positive Independent Data Monitoring Committee Recommendation GANX GlobeNewswire
Aug-12	Gain Therapeutics Reports Financial Results for Second Quarter 2025 and Provides Corporate Update GANX GlobeNewswire
Jul-24	Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference GANX GlobeNewswire
Jul-16	Gain Therapeutics Announces Pricing of $7.0 Million Public Offering GANX GlobeNewswire
Jul-15	Gain Therapeutics Announces Proposed Public Offering GANX GlobeNewswire
Jun-30	Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson's Disease With or Without a GBA1 Mutation GANX GlobeNewswire
Jun-10	Gain Therapeutics to Participate in Upcoming Investor Conferences GANX GlobeNewswire
May-29	Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting GANX GlobeNewswire
May-14	Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update GANX GlobeNewswire
May-12	Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson's Disease and Related Disorders GANX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.